pharma · severe uncontrolled asthma · mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD) · GENB
Generate Biomedicines
Generate Biomedicines clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Somerville, USA
- Employees
- 325
- Programs
- 8
- Drugs
- 7
- Patents
- 1
Generate Biomedicines projects
6 ClinicalTrials.gov programs sponsored by Generate Biomedicines.
Generate Biomedicines has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
GB-0669
Generate Biomedicines
SARS CoV-2
1 trial -
GB-0895 (SC)
Generate Biomedicines
Asthma
1 trial -
GB-0895-101
Generate Biomedicines
mild to moderate asthma, Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
GB-4362
Generate Biomedicines
Advanced Urothelial Cancer
1 trial -
GB-5267 - IV only
Generate Biomedicines
Platinum-resistant Ovarian Cancer
1 trial -
GB-7624
Generate Biomedicines
Atopic Dermatitis (AD)
1 trial
Frequently asked questions
How many clinical projects does Generate Biomedicines have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.